Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – “Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more”

Apr 4, 2024

Bill Newell describes this week’s deal with Ipsen, the folate receptor alpha space, designing therapies with non-cell protein synthesis, and Sutro’s numerous partnerships

Speakers:

  • Bill Newell, CEO, Sutro Biopharma
  • Bard Loncar, Founder, Biotech TV